{"entity":{"id":"nct03537690","kind":"trial","name":"FID-007 in Treating Participants With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of FID-007 run by University of Southern California, active and no longer recruiting.","summary":"FID-007 in Treating Participants With Advanced Solid Tumors is a phase 1 interventional study registered as NCT03537690 by University of Southern California, with 50 participants planned, started 2018-05-25. Conditions recorded: Advanced Malignant Solid Neoplasm and Refractory Malignant Solid Neoplasm. Interventions recorded: Laboratory Biomarker Analysis, PEOX-based Polymer Encapsulated Paclitaxel FID-007 and Pharmacokinetic Study.","status":"active","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03537690","url":"https://clinicaltrials.gov/study/NCT03537690"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["fid-007"],"companies":["fulgent-genetics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03537690","phase":"1","setting":"A Phase I Study of FID-007 in Patients With Advanced Solid Tumors","sponsor":"University of Southern California","enrolled":50,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03537690/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"fid-007","kind":"drug","name":"FID-007","route":"/drugs/fid-007/"}],"company":[{"id":"fulgent-genetics","kind":"company","name":"Fulgent Genetics","route":"/companies/fulgent-genetics/"}]}}